“BCL-2 TARGETED STRUCTURAL BASED COMPUTER AIDED DRUG DESIGN (CAAD) FOR THERAPEUTIC ASSESSMENT OF RICIN IN PROSTATE CANCER”, Int. J. Pharm. Sci. Drug Res., vol. 7, no. 2, pp. 168–171, Sep. 2018, doi: 10.25004/IJPSDR.2015.070207.